It is a tumor marker for cancer of the colon and rectum
The carcinoembryonic antigen (CEA) test is a laboratory blood study.
There are two common oncofetal antigens, alphafetoprotein (AFP) and carcinoembryonic antigen (CEA). Carcinoembryonic antigen CA 72-4 is a more recently discovered oncofetal antigen just coming into usage.
There are two common oncofetal antigens, alphafetoprotein (AFP) and carcinoembryonic antigen (CEA). Carcinoembryonic antigen CA 72-4 is a more recently discovered oncofetal antigen just coming into usage.
carcinoembryonic antigen (CEA)
carcinoembryonic antigen, it is a tumor marker test.
alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), prostate specific antigen (PSA), cathespin-D, HER-2/neu, CA-125, CA-19-9, CA-15-3, nuclear matrix protein, and bladder tumor-associated antigen
CEA is an acronym for carcinoembryonic antigen. Doctors will test the blood for CEA levels if they suspect cancer or to see if cancer treatment is helping.
Once treatment for the cancer has begun, CEA tests have a valuable role in monitoring the patient's progress.
CEA is a substance which is normally found only during fetal development, but may reappear in adults who develop certain types of cancer.
But it does not give clear-cut information. The results of a CEA test are usually considered along with other laboratory and/or imaging studies to follow the course of the disease.
carcinoembryonic antigen, it is a tumor marker test.
The more recently identified carcinoembryonic protein is CA 72-4. Although it is slightly elevated with most carcinomas, it is mostly associated with gastric carcinoma (stomach cancer).